791 related articles for article (PubMed ID: 27368076)
1. Patterns of Care and Comparative Effectiveness of Intensified Adjuvant Therapy for Resected Oropharyngeal Squamous Cell Carcinoma in the Human Papillomavirus Era.
Sher DJ; Nedzi L; Khan S; Hughes R; Sumer BD; Myers LL; Truelson JM; Koshy M
JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):777-88. PubMed ID: 27368076
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
[TBL] [Abstract][Full Text] [Related]
3. Predictors of overall survival in human papillomavirus-associated oropharyngeal cancer using the National Cancer Data Base.
Amini A; Jasem J; Jones BL; Robin TP; McDermott JD; Bhatia S; Raben D; Jimeno A; Bowles DW; Karam SD
Oral Oncol; 2016 May; 56():1-7. PubMed ID: 27086480
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Patients With Single-Node Metastasis of Human Papillomavirus-Related Oropharyngeal Cancer Treated With Transoral Surgery.
Chen SY; Sinha P; Last A; Ettyreddy A; Kallogjeri D; Pipkorn P; Rich JT; Zevallos JP; Paniello R; Puram SV; Van Abel K; Moore EJ; Oppelt P; Palka K; Adkins D; Daly M; Gay H; Thorstad WL; Jackson RS
JAMA Otolaryngol Head Neck Surg; 2021 Jan; 147(1):16-22. PubMed ID: 33151273
[TBL] [Abstract][Full Text] [Related]
5. Association of Extracapsular Spread With Survival According to Human Papillomavirus Status in Oropharynx Squamous Cell Carcinoma and Carcinoma of Unknown Primary Site.
Kharytaniuk N; Molony P; Boyle S; O'Leary G; Werner R; Heffron C; Feeley L; Sheahan P
JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):683-690. PubMed ID: 27196434
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
[TBL] [Abstract][Full Text] [Related]
7. Utility of up-front transoral robotic surgery in tailoring adjuvant therapy.
Gildener-Leapman N; Kim J; Abberbock S; Choby GW; Mandal R; Duvvuri U; Ferris RL; Kim S
Head Neck; 2016 Aug; 38(8):1201-7. PubMed ID: 27225507
[TBL] [Abstract][Full Text] [Related]
8. Primary surgery for human papillomavirus-associated oropharyngeal cancer: Survival outcomes with or without adjuvant treatment.
Cramer JD; Ferris RL; Kim S; Duvvuri U
Oral Oncol; 2018 Dec; 87():170-176. PubMed ID: 30527235
[TBL] [Abstract][Full Text] [Related]
9. The Role of Adjuvant Chemotherapy in Surgically Managed, p16-Positive Oropharyngeal Squamous Cell Carcinoma.
Skillington SA; Kallogjeri D; Lewis JS; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2017 Mar; 143(3):253-259. PubMed ID: 27918781
[TBL] [Abstract][Full Text] [Related]
10. Risk of Pathologic Extranodal Extension and Other Adverse Features After Transoral Robotic Surgery in Patients With HPV-Positive Oropharynx Cancer.
Zebolsky AL; George E; Gulati A; Wai KC; Carpenter P; Van Zante A; Ha PK; Heaton CM; Ryan WR
JAMA Otolaryngol Head Neck Surg; 2021 Dec; 147(12):1080-1088. PubMed ID: 34673904
[TBL] [Abstract][Full Text] [Related]
11. Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinoma.
Zenga J; Jackson RS; Graboyes EM; Sinha P; Lindberg M; Martin EJ; Ma D; Thorstad WL; Rich JT; Moore EJ; Haughey BH
Laryngoscope; 2017 Mar; 127(3):623-630. PubMed ID: 27634021
[TBL] [Abstract][Full Text] [Related]
12. Variation in use of postoperative chemoradiation following surgery for T1 and T2 oropharyngeal squamous cell carcinoma; National Cancer Database.
Roman BR; Baxi SS; Cracchiolo JR; Blackwell TJ; Pfister DG; McBride S; Ganly I; Shah JP; Patel SG; Morris LG; Cohen MA
J Surg Oncol; 2017 Sep; 116(3):351-358. PubMed ID: 28570758
[TBL] [Abstract][Full Text] [Related]
13. Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
Trosman SJ; Koyfman SA; Ward MC; Al-Khudari S; Nwizu T; Greskovich JF; Lamarre ED; Scharpf J; Khan MJ; Lorenz RR; Adelstein DJ; Burkey BB
JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):457-62. PubMed ID: 25742025
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of induction chemotherapy for oropharyngeal squamous cell carcinoma: A population-based analysis.
Sher DJ; Schwartz DL; Nedzi L; Khan S; Hughes R; Fidler MJ; Koshy M
Oral Oncol; 2016 Mar; 54():58-67. PubMed ID: 26794877
[TBL] [Abstract][Full Text] [Related]
15. Treatment Outcomes for T4 Oropharyngeal Squamous Cell Carcinoma.
Zenga J; Wilson M; Adkins DR; Gay HA; Haughey BH; Kallogjeri D; Michel LS; Paniello RC; Rich JT; Thorstad WL; Nussenbaum B
JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1118-27. PubMed ID: 25902372
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Survival Outcomes Among Human Papillomavirus-Negative cT1-2 N1-2b Patients With Oropharyngeal Squamous Cell Cancer Treated With Upfront Surgery vs Definitive Chemoradiation Therapy: An Observational Study.
Kelly JR; Park HS; An Y; Contessa JN; Yarbrough WG; Burtness BA; Decker R; Husain Z
JAMA Oncol; 2017 Aug; 3(8):1107-1111. PubMed ID: 28056116
[TBL] [Abstract][Full Text] [Related]
17. Extracapsular spread and adjuvant therapy in human papillomavirus-related, p16-positive oropharyngeal carcinoma.
Sinha P; Lewis JS; Piccirillo JF; Kallogjeri D; Haughey BH
Cancer; 2012 Jul; 118(14):3519-30. PubMed ID: 22086669
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
Haughey BH; Sinha P
Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
[TBL] [Abstract][Full Text] [Related]
19. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
[TBL] [Abstract][Full Text] [Related]
20. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.
Howard J; Dwivedi RC; Masterson L; Kothari P; Quon H; Holsinger FC
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012939. PubMed ID: 30550641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]